4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile

We are 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile CAS:214470-68-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile
CAS.NO:214470-68-5
Synonyms:7-(3-chloro-propoxy)-4-chloro-6-methoxy-quinoline-3-carbonitrile
4-chloro-3-cyano-6-methoxy-7-(3-chloropropoxy)quinoline
Molecular Formula:C14H12Cl2N2O2
Molecular Weight:311.16300
 
Physical and Chemical Properties:
Density:1.37
Boiling point:478.1ºC
Flash point:243ºC
Index of Refraction:1.607
 
Specification:
Appearance:White powder
Purity:≥98.0%
Loss on drying:≤2.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bosutinib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile


Related News: Any drug or medication is composed of two components.4,6-Dichloro-2-methylpyrimidine Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.(S)-(-)-1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid CAS:74163-81-8 Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.2-Isopropylphenol The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.

Related Products
Product Name
methyl 3,3-dimethylacrylate View Details
4-Hydrazinobenzoic acid View Details
2,2′-O-Anhydro-(1-β-D-arabinofuranosyl)uracil View Details
Sodium Metaphosphate manufacturer 5-METHYLQUINOXALINE manufacturer N-([1,1′-biphenyl]-4-yl)-[1,1′-biphenyl]-2-amine manufacturer UV Absorber 571 manufacturer 2-Chloro-3-fluoro-4-iodopyridine manufacturer